Advances in Statin Therapy and Beyond in CVD (ASTC): A Textbook of Cardiology: Chopra, H. K., Nanda, Navin C., Narula, Jagat, Wander, GS, Manjunath, CN: 9789354653933: Amazon.com: Books
PCSK9 Inhibitors in Lipid Management of Patients With Diabetes Mellitus and High Cardiovascular Risk: A Review | Journal of the American Heart Association
A New Era in Lipid Lowering Therapy: An update on PCSK9 Inhibition - BroadcastMed
Lipid-Lowering Therapy and Hemorrhagic Stroke Risk | Stroke
Frontiers | PCSK9 inhibitors for acute coronary syndrome: the era of early implementation
Nutrients | Free Full-Text | Naturally Occurring PCSK9 Inhibitors
PCSK9 Inhibitors: Ushering in a new era of Cholesterol Busters. A Comprehensive Review. - Kindle edition by Saboowala, Dr. Hakim, Saboowala, Dr. Hakim. Professional & Technical Kindle eBooks @ Amazon.com.
Frontiers | PCSK9 Inhibition: Insights From Clinical Trials and Future Prospects
PCSK9 Inhibitors Topic Review | Learn the Heart
The Evolving Future of PCSK9 Inhibitors | Journal of the American College of Cardiology
Cells | Free Full-Text | PCSK9 Inhibition: From Current Advances to Evolving Future
The effects of proprotein convertase subtilisin/kexin type 9 inhibitors on lipid metabolism and cardiovascular function - ScienceDirect
PCSK9-targeted therapies: present and future approaches | Nature Reviews Cardiology
The Evolving Future of PCSK9 Inhibitors - ScienceDirect
Frontiers | PCSK9 Inhibition: Insights From Clinical Trials and Future Prospects
A Comprehensive Review of PCSK9 Inhibitors - Caroline Coppinger, Mohammad Reza Movahed, Veronica Azemawah, Lee Peyton, James Gregory, Mehrnoosh Hashemzadeh, 2022
JCM | Free Full-Text | Soluble PCSK9 Inhibition: Indications, Clinical Impact, New Molecular Insights and Practical Approach—Where Do We Stand?
PCSK9 inhibition as an emerging lipid lowering therapy: Unanswered questions - ScienceDirect
Mechanisms of unusual response to lipid-lowering therapy: PCSK9 inhibition - ScienceDirect
Recent Update on the Development of PCSK9 Inhibitors for Hypercholesterolemia Treatment | Journal of Medicinal Chemistry
Recent Update on the Development of PCSK9 Inhibitors for Hypercholesterolemia Treatment | Journal of Medicinal Chemistry
Recent Update on the Development of PCSK9 Inhibitors for Hypercholesterolemia Treatment | Journal of Medicinal Chemistry
Complementing the "Gold Standard": Exploring PCSK9 MOA with Current Lipid Therapies (Transcript)
Reduction of LDL Cholesterol by 25% to 60% in Patients With Primary Hypercholesterolemia by Atorvastatin, a New HMG-CoA Reductase Inhibitor | Arteriosclerosis, Thrombosis, and Vascular Biology
